Please use this identifier to cite or link to this item:
|Title:||Hepatitis C virus infection in haemodialysis patients||Authors:||Roger, Simon D ;Crewe, E.;Cunningham, A.;Harris, D.C.||Issue Date:||Feb-1991||Source:||Volume 21, Issue 1, pp. 22-24||Journal title:||Australian and New Zealand Journal of Medicine||Abstract:||Antibody to hepatitis C has been variously detected in 1-20% of haemodialysis patients in recent studies from overseas. To determine the frequency of antibodies to the C100-3 protein of the hepatitis C virus (anti-HCV) a cross-sectional study was performed in 60 patients on maintenance haemodialysis in Western Sydney. Six patients (10%) were anti-HCV seropositive. Four of the six anti-HCV positive patients were also hepatitis B core antibody positive, compared with nine of 54 anti-HCV negative patients (p less than 0.05). All anti-HCV positive patients had received multiple blood transfusions. Serum alanine aminotransferase (ALT) was not useful as a screening test. Recent evidence suggests that anti-HCV seropositivity underestimates infectivity.||URI:||https://elibrary.cclhd.health.nsw.gov.au/cclhdjspui/handle/1/239||ISSN:||0004-8291||Publicaton type:||Journal Article||Keywords:||Dialysis
|Appears in Collections:||Renal Medicine|
Show full item record
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.